See also this year's filing and all EDGAR filings for this company.
PDF Report 0001587221_2020_Zosano_Pharma_Corp.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001587221')"} |
Graph
Absolute values for 0001587221, Zosano Pharma Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,813,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 24,636,000 |
| 3 | remainder_Assets | 6,221,000 |
| 4 | LiabilitiesCurrent | 16,237,000 |
| 5 | LiabilitiesNoncurrent | 5,931,000 |
| 6 | remainder_Liabilities | 6,110,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,812,000 |
| 9 | ResearchAndDevelopmentExpense | 25,385,000 |
| 10 | remainder_Expenses | 523,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 131,000 |
| 13 | remainder_ComprehensiveNetIncome | 5,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,670,000 |
| 1 | Liabilities | 28,278,000 |
| 2 | Expenses | 37,720,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 9,392,000 |
| 5 | NetIncome | -37,589,000 |
| 6 | ComprehensiveNetIncome | -37,586,500 |
| 7 | BaseVar | 51,902,000 |
| 8 | EconomicCapitalRatio | -0.650 |
Edgar->Model Mapping
Feature Distribution
Change over Time
